Bocouture Provides Advantages of
Bocouture Provides Advantages of
Bocouture Provides Advantages of
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
36 year old female before Tx<br />
36 year old female two weeks after <strong>Bocouture</strong> Tx<br />
Photos courtesy <strong>of</strong> David Eccleston, M.D., M.B., Ch.B.,<br />
M.B.A.C.D., M.S.C.P.S.<br />
36 year old female before Tx<br />
36 year old female two weeks after <strong>Bocouture</strong> Tx<br />
Photos courtesy <strong>of</strong> David Eccleston, M.D., M.B., Ch.B.,<br />
M.B.A.C.D., M.S.C.P.S.<br />
3 THE European Aesthetic Guide Spring 2011 www.miinews.com<br />
treatment regimes. “You can’t have a<br />
1:1 conversion with other neurotoxin<br />
products, and there is no fixed dosage<br />
conversion ratio,” explained<br />
David Eccleston, M.D., M.B., Ch.B.,<br />
M.B.A.C.D., M.S.C.P.S., clinical director<br />
<strong>of</strong> MediZen, Ltd. (Mere Green,<br />
Sutton Coldfield, U.K.). “Most physicians<br />
are using a 2.5:1 or 3:1 ratio<br />
with other neurotoxins versus <strong>Bocouture</strong><br />
or Vistabel. There is no proven<br />
equivalence.”<br />
David Eccleston, M.D., M.B.,<br />
Ch.B., M.B.A.C.D., M.S.C.P.S.<br />
Clinical Director<br />
MediZen, Ltd.<br />
Mere Green, Sutton Coldfield, U.K.<br />
Dr. Eccleston also noted that an experienced<br />
injector can easily begin using<br />
<strong>Bocouture</strong> and can expect results<br />
similar to those achieved with other<br />
neurotoxins on the market. “I’ve been<br />
using neurotoxins for 16 years and I<br />
believe that <strong>Bocouture</strong> is a useful tool<br />
to have in my arsenal. In my opinion, it<br />
delivers equivalent efficacy and tolerability<br />
to Vistabel; therefore, I believe<br />
<strong>Bocouture</strong> is here to stay,” he said.<br />
Other advantages <strong>of</strong> <strong>Bocouture</strong> include<br />
a fast onset <strong>of</strong> effect from day<br />
one onwards. 3 As well; its ability to<br />
maintain stability at room temperature<br />
for three years means that it does not<br />
require a cold chain and does not<br />
have to be stored in a refrigerator.<br />
To date, for aesthetic use, <strong>Bocouture</strong><br />
is marketed in Germany, the U.K.,<br />
France, Spain, Italy, the Netherlands<br />
and Belgium. The product is marketed<br />
as Xeomin in Russia and Argentina,<br />
and as Xeomeen in Mexico. Botulinum<br />
toxin type A preparations from Merz<br />
have been used in therapeutic and aesthetic<br />
indications in more than 120,000<br />
patients worldwide and in more than<br />
1,500 patients in clinical trials. Safety<br />
and efficacy have been successfully<br />
demonstrated in both indications.<br />
According to experts there is a<br />
growing trend for full-face treatments 5 .<br />
This trend is supported by the Merz<br />
Aesthetics Face Value Beauty Survey<br />
conducted by Harris Interactive among<br />
2,900 women 6 located in France, Italy,<br />
Spain, Russia and the U.K. The survey<br />
revealed that patients most <strong>of</strong>ten see<br />
their physician for multiple problem areas.<br />
Additionally, approximately one in<br />
two patients decided to treat other areas<br />
after consulting with their physician<br />
or aesthetic practitioner.<br />
Given that nearly half <strong>of</strong> women want<br />
to improve or change wrinkles around<br />
their eyes, mouth or in their forehead,<br />
it can be expected that botulinum toxin<br />
will maintain its position as a core<br />
tool in aesthetics with interest also<br />
continuing to increase in other therapeutic<br />
areas.<br />
*<strong>Bocouture</strong> is indicated for the temporary<br />
improvement in the appearance <strong>of</strong> moderate<br />
to severe vertical lines between the eye brow<br />
seen at frown, in adults